OBJECTIVE: To obtain quantitative neurometabolite measurements, specifically myoinositol (mI) and glutamate plus glutamine (Glx), markers of glial and neuronal excitation, in deep gray matter structures after mild traumatic brain injury (mTBI) using proton magnetic resonance spectroscopy ((1)H-MRS) and to compare these measurements against normal healthy control subjects. METHODS: This study approved by the institutional review board is Health Insurance Portability and Accountability Act compliant. T1-weighted MRI and multi-voxel (1)H-MRS imaging were acquired at 3 tesla from 26 patients with mTBI an average of 22 days postinjury and from 13 age-matched healthy controls. Two-way analysis of variance was used to compare patients and controls for mean N-acetylaspartate, choline, creatine (Cr), Glx, and mI levels as well as the respective ratios to Cr within the caudate, globus pallidus, putamen, and thalamus. RESULTS: Quantitative putaminal mI was higher in patients with mTBI compared with controls (p = 0.02). Quantitative neurometabolite ratios of putaminal mI and Glx relative to Cr, mI/Cr, and Glx/Cr were also higher among patients with mTBI compared with controls (p = 0.01 and 0.02, respectively). No other differences in neurometabolite levels or ratios were observed in any other brain region evaluated. CONCLUSION: Increased putaminal mI, mI/Cr, and Glx/Cr in patients after mTBI compared with control subjects supports the notion of a complex glial and excitatory response to injury without concomitant neuronal loss, evidenced by preserved N-acetylaspartate levels in this region.
OBJECTIVE: To obtain quantitative neurometabolite measurements, specifically myoinositol (mI) and glutamate plus glutamine (Glx), markers of glial and neuronal excitation, in deep gray matter structures after mild traumatic brain injury (mTBI) using proton magnetic resonance spectroscopy ((1)H-MRS) and to compare these measurements against normal healthy control subjects. METHODS: This study approved by the institutional review board is Health Insurance Portability and Accountability Act compliant. T1-weighted MRI and multi-voxel (1)H-MRS imaging were acquired at 3 tesla from 26 patients with mTBI an average of 22 days postinjury and from 13 age-matched healthy controls. Two-way analysis of variance was used to compare patients and controls for mean N-acetylaspartate, choline, creatine (Cr), Glx, and mI levels as well as the respective ratios to Cr within the caudate, globus pallidus, putamen, and thalamus. RESULTS: Quantitative putaminal mI was higher in patients with mTBI compared with controls (p = 0.02). Quantitative neurometabolite ratios of putaminal mI and Glx relative to Cr, mI/Cr, and Glx/Cr were also higher among patients with mTBI compared with controls (p = 0.01 and 0.02, respectively). No other differences in neurometabolite levels or ratios were observed in any other brain region evaluated. CONCLUSION: Increased putaminal mI, mI/Cr, and Glx/Cr in patients after mTBI compared with control subjects supports the notion of a complex glial and excitatory response to injury without concomitant neuronal loss, evidenced by preserved N-acetylaspartate levels in this region.
Authors: Changho Choi; Nicholas J Coupland; Paramjit P Bhardwaj; Sanjay Kalra; Colin A Casault; Kim Reid; Peter S Allen Journal: Magn Reson Med Date: 2006-11 Impact factor: 4.668
Authors: M Smits; M G M Hunink; D A van Rijssel; H M Dekker; P E Vos; D R Kool; P J Nederkoorn; P A M Hofman; A Twijnstra; H L J Tanghe; D W J Dippel Journal: AJNR Am J Neuroradiol Date: 2007-12-07 Impact factor: 3.825
Authors: Ivan Kirov; Lazar Fleysher; James S Babb; Jonathan M Silver; Robert I Grossman; Oded Gonen Journal: Brain Inj Date: 2007-10 Impact factor: 2.311
Authors: Stefan Posse; Ricardo Otazo; Arvind Caprihan; Juan Bustillo; Hongji Chen; Pierre-Gilles Henry; Malgorzata Marjanska; Charles Gasparovic; Chun Zuo; Vincent Magnotta; Bryon Mueller; Paul Mullins; Perry Renshaw; Kamil Ugurbil; Kelvin O Lim; Jeffry R Alger Journal: Magn Reson Med Date: 2007-08 Impact factor: 4.668
Authors: José M Pascual; Juan Solivera; Ruth Prieto; Laura Barrios; Pilar López-Larrubia; Sebastian Cerdán; José M Roda Journal: J Neurotrauma Date: 2007-06 Impact factor: 5.269
Authors: Gadi Goelman; Songtao Liu; Roman Fleysher; Lazar Fleysher; Robert I Grossman; Oded Gonen Journal: Magn Reson Med Date: 2007-07 Impact factor: 3.737
Authors: Andrew A Maudsley; Varan Govind; Gaurav Saigal; Stuart G Gold; Leo Harris; Sulaiman Sheriff Journal: J Neuroimaging Date: 2017-07-23 Impact factor: 2.486
Authors: Inga K Koerte; Alexander P Lin; Marc Muehlmann; Sai Merugumala; Huijun Liao; Tyler Starr; David Kaufmann; Michael Mayinger; Denise Steffinger; Barbara Fisch; Susanne Karch; Florian Heinen; Birgit Ertl-Wagner; Maximilian Reiser; Robert A Stern; Ross Zafonte; Martha E Shenton Journal: J Neurotrauma Date: 2015-05-14 Impact factor: 5.269
Authors: Amy L Schranz; Kathryn Y Manning; Gregory A Dekaban; Lisa Fischer; Tatiana Jevremovic; Kevin Blackney; Christy Barreira; Timothy J Doherty; Douglas D Fraser; Arthur Brown; Jeff Holmes; Ravi S Menon; Robert Bartha Journal: Hum Brain Mapp Date: 2017-12-21 Impact factor: 5.038
Authors: Christopher R Dorsett; Jennifer L McGuire; Erica A K DePasquale; Amanda E Gardner; Candace L Floyd; Robert E McCullumsmith Journal: J Neurotrauma Date: 2016-07-06 Impact factor: 5.269
Authors: Brenda L Bartnik-Olson; Jeffry R Alger; Talin Babikian; Ashley D Harris; Barbara Holshouser; Ivan I Kirov; Andrew A Maudsley; Paul M Thompson; Emily L Dennis; David F Tate; Elisabeth A Wilde; Alexander Lin Journal: Brain Imaging Behav Date: 2021-04 Impact factor: 3.978